• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺泡横纹肌肉瘤组织学与PAX/FKHR融合状态之间的相关性:来自儿童肿瘤学组的报告

Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.

作者信息

Parham David M, Qualman Stephen J, Teot Lisa, Barr Frederic G, Morotti Raphaella, Sorensen Poul H B, Triche Timothy J, Meyer William H

机构信息

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

出版信息

Am J Surg Pathol. 2007 Jun;31(6):895-901. doi: 10.1097/01.pas.0000213436.99492.51.

DOI:10.1097/01.pas.0000213436.99492.51
PMID:17527077
Abstract

At the molecular level, alveolar rhabdomyosarcomas (ARMS) are characterized by 3 mutually exclusive PAX/FKHR conditions: PAX3/FKHR fusion (present in 60% of cases), PAX7/FKHR fusion (present in 20%), and PAX/FKHR fusion-negativity (present in 20%). The possibility of morphologic variation among these molecular subtypes has not been investigated. We undertook a blinded retrospective study of 65 cases of ARMS (16 PAX/FKHR fusion-negative, 36 PAX3/FKHR-positive, and 13 PAX7/FKHR-positive by routine reverse transcription-polymerase chain reaction). We evaluated cytohistologic parameters such as microcyst formation, solid foci, differentiation, giant cell formation, anaplasia, nuclear grade, mitosis/karyorrhexis index, rosette formation, geographic necrosis, presence and amount of rhabdomyoblastic differentiation, and the presence of foci resembling embryonal rhabdomyosarcoma. We analyzed the results using a simple chi formula. Of these features, only totally solid alveolar architecture reached significance (P=0.00014), with 7 of 16 PAX/FKHR-negative cases lacking this feature, compared with 0 of 36 PAX3/FKHR cases and 2/13 PAX7/FKHR cases. These preliminary results indicate that in general, only totally solid alveolar architecture in ARMS may predict the absence of a PAX/FKHR fusion. No features seemed to predict the presence of a particular fusion type. Our results suggest that histologic assessment of ARMS has limited correlation with PAX/FKHR fusion status.

摘要

在分子水平上,肺泡状横纹肌肉瘤(ARMS)具有三种相互排斥的PAX/FKHR情况:PAX3/FKHR融合(60%的病例中存在)、PAX7/FKHR融合(20%中存在)以及PAX/FKHR融合阴性(20%中存在)。尚未对这些分子亚型之间形态学变异的可能性进行研究。我们对65例ARMS进行了一项盲法回顾性研究(通过常规逆转录-聚合酶链反应,16例PAX/FKHR融合阴性,36例PAX3/FKHR阳性,13例PAX7/FKHR阳性)。我们评估了细胞组织学参数,如微囊肿形成、实性病灶、分化、巨细胞形成、间变、核分级、有丝分裂/核溶解指数、菊形团形成、地图状坏死、横纹肌母细胞分化的存在及数量,以及类似胚胎性横纹肌肉瘤病灶的存在情况。我们使用简单的卡方公式分析结果。在这些特征中,只有完全实性的肺泡结构具有统计学意义(P = 0.00014),16例PAX/FKHR阴性病例中有7例缺乏此特征,而36例PAX3/FKHR病例中为0例,13例PAX7/FKHR病例中为2例。这些初步结果表明,一般来说,ARMS中只有完全实性肺泡结构可能预示PAX/FKHR融合的缺失。似乎没有特征能预测特定融合类型的存在。我们的结果表明,ARMS的组织学评估与PAX/FKHR融合状态的相关性有限。

相似文献

1
Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.肺泡横纹肌肉瘤组织学与PAX/FKHR融合状态之间的相关性:来自儿童肿瘤学组的报告
Am J Surg Pathol. 2007 Jun;31(6):895-901. doi: 10.1097/01.pas.0000213436.99492.51.
2
Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.PAX-FKHR融合阳性的肺泡型和PAX-FKHR融合阴性的胚胎型横纹肌肉瘤的全基因组表达谱分析
J Pathol. 2007 Jun;212(2):143-51. doi: 10.1002/path.2170.
3
Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.表达PAX-FKHR的小鼠间充质干细胞通过与二次突变协同作用形成肺泡横纹肌肉瘤。
Cancer Res. 2008 Aug 15;68(16):6587-97. doi: 10.1158/0008-5472.CAN-08-0859.
4
PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.PAX3 - FKHR和PAX7 - FKHR基因融合是肺泡横纹肌肉瘤的预后指标:来自儿童肿瘤学组的报告。
J Clin Oncol. 2002 Jun 1;20(11):2672-9. doi: 10.1200/JCO.2002.03.137.
5
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.鉴定一种PAX-FKHR基因表达特征,该特征可定义分子类别并决定肺泡横纹肌肉瘤的预后。
Cancer Res. 2006 Jul 15;66(14):6936-46. doi: 10.1158/0008-5472.CAN-05-4578.
6
Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.无典型基因融合的肺泡横纹肌肉瘤亚组中的遗传异质性。
Cancer Res. 2002 Aug 15;62(16):4704-10.
7
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.肺泡横纹肌肉瘤中涉及PAX和FOX家族成员的基因融合。
Oncogene. 2001 Sep 10;20(40):5736-46. doi: 10.1038/sj.onc.1204599.
8
[Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma].[横纹肌肉瘤中融合基因PAX3/PAX7-FKHR的表达及染色体畸变]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Feb;24(1):42-7.
9
Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.Pax3-fkhr和pax7-fkhr融合基因影响儿童肺泡横纹肌肉瘤的预后。
Fetal Pediatr Pathol. 2007 Jan-Feb;26(1):17-31. doi: 10.1080/15513810701394702.
10
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?小儿横纹肌肉瘤中PAX3-FKHR融合基因的检测:一种可重复的预后预测指标?
Br J Cancer. 2001 Sep 14;85(6):831-5. doi: 10.1054/bjoc.2001.2008.

引用本文的文献

1
Prognostic factors in patients with localized and metastatic alveolar rhabdomyosarcoma. A report from two studies and two registries of the Cooperative Weichteilsarkom Studiengruppe CWS.局限性和转移性肺泡横纹肌肉瘤患者的预后因素。来自合作软组织肉瘤研究组CWS的两项研究和两个登记处的报告。
Cancer Med. 2025 Jan;14(1):e70215. doi: 10.1002/cam4.70215.
2
Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.会阴和肛周横纹肌肉瘤患者的结局:来自儿童肿瘤学组软组织肉瘤委员会的报告。
Pediatr Blood Cancer. 2024 Nov;71(11):e31303. doi: 10.1002/pbc.31303. Epub 2024 Sep 3.
3
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.
KDM3B 抑制剂破坏融合阳性横纹肌肉瘤中 PAX3-FOXO1 的致癌活性。
Nat Commun. 2024 Feb 24;15(1):1703. doi: 10.1038/s41467-024-45902-y.
4
Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.肺泡横纹肌肉瘤在复发性/难治性疾病患者中的长春瑞滨缓解率优于胚胎性横纹肌肉瘤:一项荟萃分析。
Cancer Med. 2023 May;12(9):10222-10229. doi: 10.1002/cam4.5749. Epub 2023 Apr 4.
5
Radiation Therapy in the Treatment of Head and Neck Rhabdomyosarcoma.放射治疗在头颈部横纹肌肉瘤治疗中的应用
Cancers (Basel). 2021 Jul 16;13(14):3567. doi: 10.3390/cancers13143567.
6
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.横纹肌肉瘤患者新型药物的优先级排序:儿童肿瘤协作组(COG)横纹肌肉瘤新型药物特别工作组的报告
J Clin Med. 2021 Apr 1;10(7):1416. doi: 10.3390/jcm10071416.
7
Bayesian Modeling Identifies PLAG1 as a Key Regulator of Proliferation and Survival in Rhabdomyosarcoma Cells.贝叶斯建模确定 PLAG1 是横纹肌肉瘤细胞增殖和存活的关键调节因子。
Mol Cancer Res. 2020 Mar;18(3):364-374. doi: 10.1158/1541-7786.MCR-19-0764. Epub 2019 Nov 22.
8
Rhabdomyosarcoma and Extraosseous Ewing Sarcoma.横纹肌肉瘤和骨外尤文肉瘤。
Children (Basel). 2018 Dec 10;5(12):165. doi: 10.3390/children5120165.
9
Li-Fraumeni Syndrome.李-弗劳梅尼综合征
J Pediatr Genet. 2016 Jun;5(2):84-8. doi: 10.1055/s-0036-1579759. Epub 2016 Apr 13.
10
DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma.DAX-1在儿童横纹肌肉瘤中的表达:一种有助于诊断易位阳性肺泡横纹肌肉瘤的免疫组织化学标志物。
PLoS One. 2015 Jul 13;10(7):e0133019. doi: 10.1371/journal.pone.0133019. eCollection 2015.